VOYA Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$502K Sell
35,908
-15,103
-30% -$211K ﹤0.01% 1896
2025
Q1
$693K Sell
51,011
-3,802
-7% -$51.7K ﹤0.01% 1721
2024
Q4
$1.12M Sell
54,813
-2,991
-5% -$61K ﹤0.01% 1539
2024
Q3
$1.68M Sell
57,804
-976
-2% -$28.4K ﹤0.01% 1397
2024
Q2
$1.36M Sell
58,780
-161,858
-73% -$3.76M ﹤0.01% 1465
2024
Q1
$4.53M Sell
220,638
-63,466
-22% -$1.3M ﹤0.01% 1049
2023
Q4
$6.1M Buy
284,104
+19,488
+7% +$418K 0.01% 922
2023
Q3
$5.46M Buy
264,616
+1,109
+0.4% +$22.9K 0.01% 934
2023
Q2
$7.78M Buy
263,507
+71,779
+37% +$2.12M 0.01% 820
2023
Q1
$4.42M Buy
191,728
+21,854
+13% +$504K ﹤0.01% 1035
2022
Q4
$4.72M Buy
169,874
+3,938
+2% +$110K 0.01% 995
2022
Q3
$5.09M Sell
165,936
-64,894
-28% -$1.99M 0.01% 943
2022
Q2
$6.79M Buy
230,830
+99,848
+76% +$2.94M 0.02% 616
2022
Q1
$4.22M Buy
130,982
+95,909
+273% +$3.09M 0.01% 887
2021
Q4
$1.56M Sell
35,073
-518
-1% -$23.1K ﹤0.01% 1280
2021
Q3
$1.8M Sell
35,591
-174
-0.5% -$8.78K ﹤0.01% 1227
2021
Q2
$2.81M Buy
35,765
+8,192
+30% +$642K 0.01% 1060
2021
Q1
$1.57M Buy
27,573
+223
+0.8% +$12.7K ﹤0.01% 1302
2020
Q4
$2.29M Buy
27,350
+5,468
+25% +$458K ﹤0.01% 1079
2020
Q3
$784K Hold
21,882
﹤0.01% 1419
2020
Q2
$529K Sell
21,882
-3,203
-13% -$77.4K ﹤0.01% 1630
2020
Q1
$439K Buy
25,085
+1,788
+8% +$31.3K ﹤0.01% 1688
2019
Q4
$406K Buy
23,297
+3,867
+20% +$67.4K ﹤0.01% 2004
2019
Q3
$298K Hold
19,430
﹤0.01% 2043
2019
Q2
$403K Buy
19,430
+829
+4% +$17.2K ﹤0.01% 1917
2019
Q1
$432K Hold
18,601
﹤0.01% 1860
2018
Q4
$384K Buy
18,601
+1,803
+11% +$37.2K ﹤0.01% 1883
2018
Q3
$365K Buy
+16,798
New +$365K ﹤0.01% 2035